Search Result "LY354740"
Progress in the Developement of Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 47-68
Author(s): A. A. Trabanco, J. M. Cid, H. Lavreysen, G. J. Macdonald, G. Tresadern
Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1 Issue: 2 Year: 2002 Page: 215-225
Author(s): Darryle D. Schoepp, Gerard J. Marek
Allosteric Modulators for mGlu Receptors
Journal: Current Neuropharmacology
Volume: 5 Issue: 3 Year: 2007 Page: 187-194
Author(s): F. Gasparini, W. Spooren
Metabotropic Glutamate Receptors in the Control of Mood Disorders
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6 Issue: 2 Year: 2007 Page: 87-100
Author(s): Jeffrey M. Witkin, Gerard J. Marek, Bryan G. Johnson, Darryle D. Schoepp
When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 26 Year: 2015 Page: 3788-3796
Author(s): Gerard J. Marek
Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 2 (mGluR2)
Journal: Current Topics in Medicinal Chemistry
Volume: 5 Issue: 9 Year: 2005 Page: 869-884
Author(s): Michael T. Rudd, John A. McCauley
Metabotropic Glutamate Receptors in Central Nervous System Diseases
Journal: Current Drug Targets
Volume: 17 Issue: 5 Year: 2016 Page: 538-616
Author(s):
Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 94-102
Author(s): Shigeyuki Chaki, Hirohiko Hikichi
Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
Journal: Current Neuropharmacology
Volume: 3 Issue: 1 Year: 2005 Page: 9-34
Author(s): Laura E. Chavez-Noriega, Michael J. Marino, Herve Schaffhauser, Una C. Campbell, P. Jeffrey Conn
Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 1 Issue: 1 Year: 2006 Page: 1-27
Author(s): Shigeyuki Chaki, Taketoshi Okubo, Yoshinori Sekiguchi